Mechanism of herbal medicine on hypertensive nephropathy (Review)
- Authors:
- Zhaocheng Dong
- Haoran Dai
- Zhandong Feng
- Wenbin Liu
- Yu Gao
- Fei Liu
- Zihan Zhang
- Na Zhang
- Xuan Dong
- Qihan Zhao
- Xiaoshan Zhou
- Jieli Du
- Baoli Liu
-
Affiliations: Beijing Hospital of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, P.R. China, Shunyi Branch, Beijing Traditional Chinese Medicine Hospital, Beijing 101300, P.R. China, Beijing Chinese Medicine Hospital Pinggu Hospital, Beijing 101200, P.R. China, Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University, Beijing 100010, P.R. China - Published online on: January 26, 2021 https://doi.org/10.3892/mmr.2021.11873
- Article Number: 234
-
Copyright: © Dong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Seccia TM, Caroccia B and Calò LA: Hypertensive nephropathy. Moving from classic to emerging pathogenetic mechanisms. J Hypertens. 35:205–212. 2017. View Article : Google Scholar : PubMed/NCBI | |
Hart PD and Bakris GL: Hypertensive nephropathy: Prevention and treatment recommendations. Expert Opin Pharmacother. 11:2675–2686. 2010. View Article : Google Scholar : PubMed/NCBI | |
Damkjær M, Isaksson GL, Stubbe J, Jensen BL, Assersen K and Bie P: Renal renin secretion as regulator of body fluid homeostasis. Pflugers Arch. 465:153–165. 2013. View Article : Google Scholar : PubMed/NCBI | |
Huang QF, Hoshide S, Cheng HM, Park S, Park CG, Chen CH, Kario K and Wang JG; Characteristics On the Management of Hypertension in Asia-Morning Hypertension Discussion Group(COME Asia MHDG), : Management of hypertension in patients with chronic kidney disease in Asia. Curr Hypertens Rev. 12:181–185. 2016. View Article : Google Scholar : PubMed/NCBI | |
Lu X and Crowley SD: Inflammation in salt-sensitive hypertension and renal damage. Curr Hypertens Rep. 20:1032018. View Article : Google Scholar : PubMed/NCBI | |
Guan Z, Makled MN and Inscho EW: Purinoceptors, renal microvascular function and hypertension. Physiol Res. 69:353–369. 2020. View Article : Google Scholar : PubMed/NCBI | |
Freedman BI and Cohen AH: Hypertension-attributed nephropathy: What's in a name? Nat Rev Nephrol. 12:27–36. 2016. View Article : Google Scholar : PubMed/NCBI | |
Kandasamy Y, Watson D and Rudd D: Biomarker of early glomerular injury in pre-eclampsia. Hypertens Pregnancy. 34:391–399. 2015. View Article : Google Scholar : PubMed/NCBI | |
Meier P: Atherosclerotic renal artery stenosis: Update on management strategies. Curr Opin Cardiol. 26:463–471. 2011. View Article : Google Scholar : PubMed/NCBI | |
Rodriguez-Iturbe B and Johnson RJ: The role of renal microvascular disease and interstitial inflammation in salt-sensitive hypertension. Hypertens Res. 33:975–980. 2010. View Article : Google Scholar : PubMed/NCBI | |
Textor SC and Lerman L: Renovascular hypertension and ischemic nephropathy. Am J Hypertens. 23:1159–1169. 2010. View Article : Google Scholar : PubMed/NCBI | |
Udani S, Lazich I and Bakris GL: Epidemiology of hypertensive kidney disease. Nat Rev Nephrol. 7:11–21. 2011. View Article : Google Scholar : PubMed/NCBI | |
Sun HJ: current opinion for hypertension in renal fibrosis. Adv Exp Med Biol. 1165:37–47. 2019. View Article : Google Scholar : PubMed/NCBI | |
Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, Woodward M, MacMahon S, Turnbull F, Hillis GS, et al: Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: Updated systematic review and meta-analysis. Lancet. 387:435–443. 2016. View Article : Google Scholar : PubMed/NCBI | |
Romero CA and Carretero OA: Tubule-vascular feedback in renal autoregulation. Am J Physiol Renal Physiol. 316:F1218–F1226. 2019. View Article : Google Scholar : PubMed/NCBI | |
Satou R, Shao W and Navar LG: Role of stimulated intrarenal angiotensinogen in hypertension. Ther Adv Cardiovasc Dis. 9:181–190. 2015. View Article : Google Scholar : PubMed/NCBI | |
Lau WL, Huisa BN and Fisher M: the cerebrovascular-chronic kidney disease connection: Perspectives and mechanisms. Transl Stroke Res. 8:67–76. 2017. View Article : Google Scholar : PubMed/NCBI | |
Ihm CG: Hypertension in chronic glomerulonephritis. Electrolyte Blood Press. 13:41–45. 2015. View Article : Google Scholar : PubMed/NCBI | |
Hughson MD, Puelles VG, Hoy WE, Douglas-Denton RN, Mott SA and Bertram JF: Hypertension, glomerular hypertrophy and nephrosclerosis: The effect of race. Nephrol Dial Transplant. 29:1399–1409. 2014. View Article : Google Scholar : PubMed/NCBI | |
D'Elia JA, Bayliss G, Gleason RE and Weinrauch LA: Cardiovascular-renal complications and the possible role of plasminogen activator inhibitor: A review. Clin Kidney J. 9:705–712. 2016. View Article : Google Scholar : PubMed/NCBI | |
Simeoni M, Armeni A, Summaria C, Cerantonio A and Fuiano G: Current evidence on the use of anti-RAAS agents in congenital or acquired solitary kidney. Ren Fail. 39:660–670. 2017. View Article : Google Scholar : PubMed/NCBI | |
Campese VM, Mitra N and Sandee D: Hypertension in renal parenchymal disease: Why is it so resistant to treatment? Kidney Int. 69:967–973. 2006. View Article : Google Scholar : PubMed/NCBI | |
Heyman SN, Khamaisi M, Rosen S and Rosenberger C: Renal parenchymal hypoxia, hypoxia response and the progression of chronic kidney disease. Am J Nephrol. 28:998–1006. 2008. View Article : Google Scholar : PubMed/NCBI | |
Lerman LO, Textor SC and Grande JP: Mechanisms of tissue injury in renal artery stenosis: Ischemia and beyond. Prog Cardiovasc Dis. 52:196–203. 2009. View Article : Google Scholar : PubMed/NCBI | |
Zeng Y, Wang X, Xie F and Zheng Z: Ischemia-induced glomerular parietal epithelial cells hyperplasia: Commonly misdiagnosed cellular crescent in renal biopsy. Pathol Res Pract. 213:982–986. 2017. View Article : Google Scholar : PubMed/NCBI | |
Nicolosi PA, Tombetti E, Maugeri N, Rovere-Querini P, Brunelli S and Manfredi AA: Vascular remodelling and mesenchymal transition in systemic sclerosis. Stem Cells Int. 2016:46368592016. View Article : Google Scholar : PubMed/NCBI | |
Rodriguez-Iturbe B, Pons H and Johnson RJ: Role of the immune system in hypertension. Physiol Rev. 97:1127–1164. 2017. View Article : Google Scholar : PubMed/NCBI | |
Frame AA and Wainford RD: Mechanisms of altered renal sodium handling in age-related hypertension. Am J Physiol Renal Physiol. 315:F1–F6. 2018. View Article : Google Scholar : PubMed/NCBI | |
Zhang C, Booz GW, Yu Q, He X, Wang S and Fan F: Conflicting roles of 20-HETE in hypertension and renal end organ damage. Eur J Pharmacol. 833:190–200. 2018. View Article : Google Scholar : PubMed/NCBI | |
Mendoza-Torres E, Oyarzún A, Mondaca-Ruff D, Azocar A, Castro PF, Jalil JE, Chiong M, Lavandero S and Ocaranza MP: ACE2 and vasoactive peptides: Novel players in cardiovascular/renal remodeling and hypertension. Ther Adv Cardiovasc Dis. 9:217–237. 2015. View Article : Google Scholar : PubMed/NCBI | |
Laurent S and Boutouyrie P: The structural factor of hypertension: Large and small artery alterations. Circ Res. 116:1007–1021. 2015. View Article : Google Scholar : PubMed/NCBI | |
Miyagawa K and Emoto N: Current state of endothelin receptor antagonism in hypertension and pulmonary hypertension. Ther Adv Cardiovasc Dis. 8:202–216. 2014. View Article : Google Scholar : PubMed/NCBI | |
Povlsen AL, Grimm D, Wehland M, Infanger M and Krüger M: The vasoactive mas receptor in essential hypertension. J Clin Med. 9:2672020. View Article : Google Scholar | |
Tracy RE: Renal vasculature in essential hypertension: A review of some contrarian evidence. Contrib Nephrol. 169:327–336. 2011. View Article : Google Scholar : PubMed/NCBI | |
Brown IAM, Diederich L, Good ME, DeLalio LJ, Murphy SA, Cortese-Krott MM, Hall JL, Le TH and Isakson BE: Vascular smooth muscle remodeling in conductive and resistance arteries in hypertension. Arterioscler Thromb Vasc Biol. 38:1969–1985. 2018. View Article : Google Scholar : PubMed/NCBI | |
Li Q, Youn JY and Cai H: Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension. J Hypertens. 33:1128–1136. 2015. View Article : Google Scholar : PubMed/NCBI | |
Xu M, Lu YP, Hasan AA and Hocher B: Plasma ET-1 concentrations are elevated in patients with hypertension-meta-analysis of clinical studies. Kidney Blood Press Res. 42:304–313. 2017. View Article : Google Scholar : PubMed/NCBI | |
Versmissen J, Mirabito Colafella KM, Koolen SLW and Danser AHJ: Vascular cardio-oncology: Vascular endothelial growth factor inhibitors and hypertension. Cardiovasc Res. 115:904–914. 2019. View Article : Google Scholar : PubMed/NCBI | |
Wu J, Agbor LN, Fang S, Mukohda M, Nair AR, Nakagawa P, Sharma A, Morgan DA, Grobe JL, Rahmouni K, et al: Failure to vasodilate in response to salt loading blunts renal blood flow and causes salt-sensitive hypertension. Cardiovasc Res. 117:308–319. 2021. View Article : Google Scholar : PubMed/NCBI | |
Hill GS: Hypertensive nephrosclerosis. Curr Opin Nephrol Hypertens. 17:266–270. 2008. View Article : Google Scholar : PubMed/NCBI | |
Zhang L, Yang L, Shergis J, Zhang L, Zhang AL, Guo X, Qin X, Johnson D, Liu X, Lu C, et al: Chinese herbal medicine for diabetic kidney disease: A systematic review and meta-analysis of randomised placebo-controlled trials. BMJ Open. 9:e0256532019. View Article : Google Scholar : PubMed/NCBI | |
Ren W, Liao J, Chen J, Li Z and Huang L: The effect of Chinese herbal medicine combined with western medicine on vascular endothelial function for patients with hypertension: Protocol for a systematic review and meta-analysis. Medicine (Baltimore). 98:e181342019. View Article : Google Scholar : PubMed/NCBI | |
Wang J, Qin T, Chen J, Li Y, Wang L, Huang H and Li J: Hyperuricemia and risk of incident hypertension: A systematic review and meta-analysis of observational studies. PLoS One. 9:e1142592014. View Article : Google Scholar : PubMed/NCBI | |
Gao X, Peleli M, Zollbrecht C, Patzak A, Persson AE and Carlström M: Adenosine A1 receptor-dependent and independent pathways in modulating renal vascular responses to angiotensin II. Acta Physiol (Oxf). 213:268–276. 2015. View Article : Google Scholar : PubMed/NCBI | |
Pojoga LH, Yao TM, Opsasnick LA, Siddiqui WT, Reslan OM, Adler GK, Williams GH and Khalil RA: Cooperative role of mineralocorticoid receptor and caveolin-1 in regulating the vascular response to low nitric oxide-high angiotensin II-induced cardiovascular injury. J Pharmacol Exp Ther. 355:32–47. 2015. View Article : Google Scholar : PubMed/NCBI | |
Yu D, Shi M, Bao J, Yu X, Li Y and Liu W: Genipin ameliorates hypertension-induced renal damage via the angiotensin II-TLR/MyD88/MAPK pathway. Fitoterapia. 112:244–253. 2016. View Article : Google Scholar : PubMed/NCBI | |
Zhang SF, Mao XJ, Jiang WM and Fang ZY: Qian Yang Yu Yin Granule protects against hypertension-induced renal injury by epigenetic mechanism linked to nicotinamide N-methyltransferase (NNMT) expression. J Ethnopharmacol. 255:1127382020. View Article : Google Scholar : PubMed/NCBI | |
Han L, Ma Y, Qin JG, Li LN, Gao YS, Zhang XY, Guo Y, Song LM, Luo YN and Chi XY: The renal protective effect of Jiangya tongluo formula, through regulation of adrenomedullin and angiotensin II, in rats with hypertensive nephrosclerosis. Evid Based Complement Alternat Med. 2015:4281062015. View Article : Google Scholar : PubMed/NCBI | |
Tian D, Ling S, Chen G, Li Y, Liu J, Ferid M and Bian K: Hypertensive nephropathy treatment by heart-protecting musk pill: A study of anti-inflammatory therapy for target organ damage of hypertension. Int J Gen Med. 4:131–139. 2011.PubMed/NCBI | |
Chen YH, Lei SS, Li B, Luo R, He X, Wang YZ, Zhou FC, Lv GY and Chen SH: Systematic understanding of the mechanisms of flos chrysanthemi indici-mediated effects on hypertension via computational target fishing. Comb Chem High Throughput Screen. 23:92–110. 2020. View Article : Google Scholar : PubMed/NCBI | |
Limón RI, Peñas E, Martínez-Villaluenga C and Frias J: Role of elicitation on the health-promoting properties of kidney bean sprouts. LWT Food Sci Technol. 56:328–334. 2014. View Article : Google Scholar | |
Chen H, Wang MC, Chen YY, Chen L, Wang YN, Vaziri ND, Miao H and Zhao YY: Alisol B 23-acetate attenuates CKD progression by regulating the renin-angiotensin system and gut-kidney axis. Ther Adv Chronic Dis. 11:20406223209200252020. View Article : Google Scholar : PubMed/NCBI | |
Chen L, Chen DQ, Wang M, Liu D, Chen H, Dou F, Vaziri ND and Zhao YY: Role of RAS/Wnt/β-catenin axis activation in the pathogenesis of podocyte injury and tubulo-interstitial nephropathy. Chem Biol Interact. 273:56–72. 2017. View Article : Google Scholar : PubMed/NCBI | |
Wang M, Chen DQ, Wang MC, Chen H, Chen L, Liu D, Zhao H and Zhao YY: Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway. Phytomedicine. 36:243–253. 2017. View Article : Google Scholar : PubMed/NCBI | |
Wang M, Chen DQ, Chen L, Liu D, Zhao H, Zhang ZH, Vaziri ND, Guo Y, Zhao YY and Cao G: Novel RAS inhibitors poricoic acid ZG and poricoic acid ZH attenuate renal fibrosis via a Wnt/β-catenin pathway and targeted phosphorylation of Smad3 signaling. J Agric Food Chem. 66:1828–1842. 2018. View Article : Google Scholar : PubMed/NCBI | |
Wang M, Chen DQ, Chen L, Cao G, Zhao H, Liu D, Vaziri ND, Guo Y and Zhao YY: Novel inhibitors of the cellular renin-angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β-catenin pathway against renal fibrosis. Br J Pharmacol. 175:2689–2708. 2018. View Article : Google Scholar : PubMed/NCBI | |
Chen H, Yang T, Wang MC, Chen DQ, Yang Y and Zhao YY: Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation. Phytomedicine. 42:207–218. 2018. View Article : Google Scholar : PubMed/NCBI | |
Zhang CC, Gu WL, Wu XM, Li YM, Chen CX and Huang XY: Active components from Radix scrophulariae inhibits the ventricular remodeling induced by hypertension in rats. Springerplus. 5:3582016. View Article : Google Scholar : PubMed/NCBI | |
Lian FZ, Cheng P, Ruan CS, Ling XX, Wang XY, Pan M, Chen ML, Shen AZ and Gao S: Xin-Ji-Er-Kang ameliorates kidney injury following myocardial infarction by inhibiting oxidative stress via Nrf2/HO-1 pathway in rats. Biomed Pharmacother. 117:1091242019. View Article : Google Scholar : PubMed/NCBI | |
Yang T, Chen YY, Liu JR, Zhao H, Vaziri ND, Guo Y and Zhao YY: Natural products against renin-angiotensin system for antifibrosis therapy. Eur J Med Chem. 179:623–633. 2019. View Article : Google Scholar : PubMed/NCBI | |
Deng YF, Aluko RE, Jin Q, Zhang Y and Yuan LJ: Inhibitory activities of baicalin against renin and angiotensin-converting enzyme. Pharm Biol. 50:401–406. 2012. View Article : Google Scholar : PubMed/NCBI | |
Lv GY, Zhang YP, Gao JL, Yu JJ, Lei J, Zhang ZR, Li B, Zhan RJ and Chen SH: Combined antihypertensive effect of luteolin and buddleoside enriched extracts in spontaneously hypertensive rats. J Ethnopharmacol. 150:507–513. 2013. View Article : Google Scholar : PubMed/NCBI | |
Zhao YY, Li HT, Feng YL, Bai X and Lin RC: Urinary metabonomic study of the surface layer of Poria cocos as an effective treatment for chronic renal injury in rats. J Ethnopharmacol. 148:403–410. 2013. View Article : Google Scholar : PubMed/NCBI | |
Zheng X, Wang S, Zou X, Jing Y, Yang R, Li S and Wang F: Ginsenoside Rb1 improves cardiac function and remodeling in heart failure. Exp Anim. 66:217–228. 2017. View Article : Google Scholar : PubMed/NCBI | |
Kaiser S, Carvalho ÂR, Pittol V, Dietrich F, Manica F, Machado MM, de Oliveira LF, Oliveira Battastini AM and Ortega GG: Genotoxicity and cytotoxicity of oxindole alkaloids from Uncaria tomentosa (cat's claw): Chemotype relevance. J Ethnopharmacol. 189:90–98. 2016. View Article : Google Scholar : PubMed/NCBI | |
Zhang RH, Liu ZK, Yang DS, Zhang XJ, Sun HD and Xiao WL: Phytochemistry and pharmacology of the genus leonurus: The herb to benefit the mothers and more. Phytochemistry. 147:167–183. 2018. View Article : Google Scholar : PubMed/NCBI | |
Rossi GP, Seccia TM, Barton M, Danser AHJ, de Leeuw PW, Dhaun N, Rizzoni D, Rossignol P, Ruilope LM, van den Meiracker AH, et al: Endothelial factors in the pathogenesis and treatment of chronic kidney disease part I: General mechanisms: A joint consensus statement from the European society of hypertension working group on endothelin and endothelial factors and the Japanese society of hypertension. J Hypertens. 36:451–461. 2018. View Article : Google Scholar : PubMed/NCBI | |
Brusilovskaya K, Königshofer P, Schwabl P and Reiberger T: Vascular targets for the treatment of portal hypertension. Semin Liver Dis. 39:483–501. 2019. View Article : Google Scholar : PubMed/NCBI | |
Westfall TC, Macarthur H, Byku M, Yang CL and Murray J: Interactions of neuropeptide y, catecholamines, and angiotensin at the vascular neuroeffector junction. Adv Pharmacol. 68:115–139. 2013. View Article : Google Scholar : PubMed/NCBI | |
Zhu X, Zhou Z, Zhang Q, Cai W, Zhou Y, Sun H and Qiu L: Vaccarin administration ameliorates hypertension and cardiovascular remodeling in renovascular hypertensive rats. J Cell Biochem. 119:926–937. 2018. View Article : Google Scholar : PubMed/NCBI | |
Jiang P, Ma D, Wang X, Wang Y, Bi Y, Yang J, Wang X and Li X: Astragaloside IV prevents obesity-associated hypertension by improving pro-inflammatory reaction and leptin resistance. Mol Cells. 41:244–255. 2018.PubMed/NCBI | |
Wang YC, Ma DF, Jiang P, Zhang YM, Zhou GF, Yang JL, Li ZY and Li X: Guizhi decoction () inhibits cholinergic transdifferentiation by regulating imbalance of NGF and LIF in salt-sensitive hypertensive heart failure rats. Chin J Integr Med. 26:188–196. 2020. View Article : Google Scholar : PubMed/NCBI | |
Xiong W, He FF, You RY, Xiong J, Wang YM, Zhang C, Meng XF and Su H: Acupuncture application in chronic kidney disease and its potential mechanisms. Am J Chin Med. 46:1169–1185. 2018. View Article : Google Scholar : PubMed/NCBI | |
Paterno JC, Bergamaschi CT, Campos RR, Higa EM, Soares MF, Schor N, Freire AO and Teixeira VP: Electroacupuncture and moxibustion decrease renal sympathetic nerve activity and retard progression of renal disease in rats. Kidney Blood Press Res. 35:355–364. 2012. View Article : Google Scholar : PubMed/NCBI | |
Yang JW, Ye Y, Wang XR, Li F, Xiao LY, Shi GX and Liu CZ: Acupuncture attenuates renal sympathetic activity and blood pressure via beta-adrenergic receptors in spontaneously hypertensive rats. Neural Plast. 2017:86964022017. View Article : Google Scholar : PubMed/NCBI | |
Mennuni S, Rubattu S, Pierelli G, Tocci G, Fofi C and Volpe M: Hypertension and kidneys: Unraveling complex molecular mechanisms underlying hypertensive renal damage. J Hum Hypertens. 28:74–79. 2014. View Article : Google Scholar : PubMed/NCBI | |
Crowley SD: The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension. Antioxid Redox Signal. 20:102–120. 2014. View Article : Google Scholar : PubMed/NCBI | |
Zhang J, An SJ, Fu JQ, Liu P, Shao TM, Li M, Li X, Jiao Z and Chai XQ: Mixed aqueous extract of Salvia miltiorrhiza reduces blood pressure through inhibition of vascular remodelling and oxidative stress in spontaneously hypertensive rats. Cell Physiol Biochem. 40:347–360. 2016. View Article : Google Scholar : PubMed/NCBI | |
Li Y, Huang C, Fu W, Zhang H, Lao Y, Zhou H, Tan H and Xu H: Screening of the active fractions from the Coreopsis tinctoria nutt. Flower on diabetic endothelial protection and determination of the underlying mechanism. J Ethnopharmacol. 253:1126452020. View Article : Google Scholar : PubMed/NCBI | |
Teles F, da Silva TM, da Cruz Júnior FP, Honorato VH, de Oliveira Costa H, Barbosa AP, de Oliveira SG, Porfírio Z, Libório AB, Borges RL and Fanelli C: Brazilian red propolis attenuates hypertension and renal damage in 5/6 renal ablation model. PLoS One. 10:e01165352015. View Article : Google Scholar : PubMed/NCBI | |
Guo H, Kuang Z, Zhang J, Zhao X, Pu P and Yan J: The preventive effect of Apocynum venetum polyphenols on D-galactose-induced oxidative stress in mice. Exp Ther Med. 19:557–568. 2020.PubMed/NCBI | |
Moodley K, Naidoo Y and Mackraj I: Effects of Tulbaghia violacea Harv. (Alliaceae) rhizome methanolic extract on kidney function and morphology in Dahl salt-sensitive rats. J Ethnopharmacol. 155:1194–1203. 2014. View Article : Google Scholar : PubMed/NCBI | |
Hamza SM and Dyck JR: Systemic and renal oxidative stress in the pathogenesis of hypertension: Modulation of long-term control of arterial blood pressure by resveratrol. Front Physiol. 5:2922014. View Article : Google Scholar : PubMed/NCBI | |
Zhu J, Zhang Y and Yang C: Protective effect of 3-n-butylphthalide against hypertensive nephropathy in spontaneously hypertensive rats. Mol Med Rep. 11:1448–1454. 2015. View Article : Google Scholar : PubMed/NCBI | |
Lin F, Huang X, Xing F, Xu L, Zhang W, Chen Z, Ke X, Song Y and Zeng Z: Semen brassicae reduces thoracic aortic remodeling, inflammation, and oxidative damage in spontaneously hypertensive rats. Biomed Pharmacother. 129:1104002020. View Article : Google Scholar : PubMed/NCBI | |
Gai Z, Wang Z, Zhang L, Ma J and Zhu Q: Paeonol protects against hypertension in spontaneously hypertensive rats by restoring vascular endothelium. Biosci Biotechnol Biochem. 83:1992–1999. 2019. View Article : Google Scholar : PubMed/NCBI | |
Lu H, Yao H, Zou R, Chen X and Xu H: Galangin suppresses renal inflammation via the inhibition of NF-κB, PI3K/AKT and NLRP3 in uric acid treated NRK-52E tubular epithelial cells. Biomed Res Int. 2019:30183572019. View Article : Google Scholar : PubMed/NCBI | |
Dong H, Ming S, Fang J, Li Y and Liu L: Icariin ameliorates angiotensin II-induced cerebrovascular remodeling by inhibiting Nox2-containing NADPH oxidase activation. Hum Cell. 32:22–30. 2019. View Article : Google Scholar : PubMed/NCBI | |
Yan D, Yue B, Qian M, Zhao L, Zhang Z, Qian H, Yan S, Qian Y and Fang Z: JYYS granule mitigates renal injury in clinic and in spontaneously hypertensive rats by inhibiting NF-κB signaling-mediated microinflammation. Evid Based Complement Alternat Med. 2018:84729632018. View Article : Google Scholar : PubMed/NCBI | |
Luo WM, Kong J, Gong Y, Liu XQ, Yang RX and Zhao YX: Tongxinluo protects against hypertensive kidney injury in spontaneously-hypertensive rats by inhibiting oxidative stress and activating forkhead box o1 signaling. PLoS One. 10:e01451302015. View Article : Google Scholar : PubMed/NCBI | |
Jiang J, Huang D, Li Y, Gan Z, Li H, Li X, Bian K and Ke Y: Heart protection by herb formula BanXia BaiZhu TianMa decoction in spontaneously hypertensive rats. Evid Based Complement Alternat Med. 2019:56129292019. View Article : Google Scholar : PubMed/NCBI | |
Ding K, Wang Y, Jiang W, Zhang Y, Yin H and Fang Z: Qian Yang Yu Yin Granule-containing serum inhibits angiotensin II-induced proliferation, reactive oxygen species production, and inflammation in human mesangial cells via an NADPH oxidase 4-dependent pathway. BMC Complement Altern Med. 15:812015. View Article : Google Scholar : PubMed/NCBI | |
Lu L, Sun X, Chen C, Qin Y and Guo X: Shexiang baoxin pill, derived from the traditional Chinese medicine, provides protective roles against cardiovascular diseases. Front Pharmacol. 9:11612018. View Article : Google Scholar : PubMed/NCBI | |
Wang XY, Huang GY, Lian FZ, Pan M, Ruan CS, Ling XX, Chen ML, Shen AZ and Gao S: Protective effect of Xin-Ji-Er-Kang on cardiovascular remodeling in high-salt induced hypertensive mice: Role ofoxidative stress and endothelial dysfunction. Biomed Pharmacother. 115:1089372019. View Article : Google Scholar : PubMed/NCBI | |
Guo K, Lan CZ, Yu TT, Huang LL, Wang XH, Pan C and Gao S: Effects of Xin-Ji-Er-Kang formula on 2K1C-induced hypertension and cardiovascular remodeling in rats. J Ethnopharmacol. 155:1227–1235. 2014. View Article : Google Scholar : PubMed/NCBI | |
Yu TT, Guo K, Chen HC, Lan CZ, Wang J, Huang LL, Wang XH, Zhang Z and Gao S: Effects of traditional Chinese medicine Xin-Ji-Er-Kang formula on 2K1C hypertensive rats: Role of oxidative stress and endothelial dysfunction. BMC Complement Altern Med. 13:1732013. View Article : Google Scholar : PubMed/NCBI | |
Liu W, Lin S, Cai Q, Zhang L, Shen A, Chen Y and Peng J: Qingxuan Jiangya decoction mitigates renal interstitial fibrosis in spontaneously hypertensive rats by regulating transforming growth factor-β1/Smad signaling pathway. Evid Based Complement Alternat Med. 2017:15763282017. View Article : Google Scholar : PubMed/NCBI | |
Qin T, Wu L, Hua Q, Song Z, Pan Y and Liu T: Prediction of the mechanisms of action of Shenkang in chronic kidney disease: A network pharmacology study and experimental validation. J Ethnopharmacol. 246:1121282020. View Article : Google Scholar : PubMed/NCBI | |
Tian XL and Li Y: Endothelial cell senescence and age-related vascular diseases. J Genet Genomics. 41:485–495. 2014. View Article : Google Scholar : PubMed/NCBI | |
Regina C, Panatta E, Candi E, Melino G, Amelio I, Balistreri CR, Annicchiarico-Petruzzelli M, Di Daniele N and Ruvolo G: Vascular ageing and endothelial cell senescence: Molecular mechanisms of physiology and diseases. Mech Ageing Dev. 159:14–21. 2016. View Article : Google Scholar : PubMed/NCBI | |
Lankhorst S, Kappers MH, van Esch JH, Danser AH and van den Meiracker AH: Hypertension during vascular endothelial growth factor inhibition: Focus on nitric oxide, endothelin-1, and oxidative stress. Antioxid Redox Signal. 20:135–145. 2014. View Article : Google Scholar : PubMed/NCBI | |
Yang X, Shao H, Chen Y, Ding N, Yang A, Tian J and Jiang Y, Li G and Jiang Y: In renal hypertension, Cirsium japonicum strengthens cardiac function via the intermedin/nitric oxide pathway. Biomed Pharmacother. 101:787–791. 2018. View Article : Google Scholar : PubMed/NCBI | |
Yoshitomi H, Zhou J, Nishigaki T, Li W, Liu T, Wu L and Gao M: Morinda citrifolia (Noni) fruit juice promotes vascular endothelium function in hypertension via glucagon-like peptide-1 receptor-CaMKKβ-AMPK-eNOS pathway. Phytother Res. 34:2341–2350. 2020. View Article : Google Scholar : PubMed/NCBI | |
Razali N, Dewa A, Asmawi MZ, Mohamed N and Manshor NM: Mechanisms underlying the vascular relaxation activities of Zingiber officinale var. rubrum in thoracic aorta of spontaneously hypertensive rats. J Integr Med. 18:46–58. 2020. View Article : Google Scholar : PubMed/NCBI | |
Akinyemi AJ, Onyebueke N, Faboya OA, Onikanni SA, Fadaka A and Olayide I: Curcumin inhibits adenosine deaminase and arginase activities in cadmium-induced renal toxicity in rat kidney. J Food Drug Anal. 25:438–446. 2017. View Article : Google Scholar : PubMed/NCBI | |
Zhang DM, Li YC, Xu D, Ding XQ and Kong LD: Protection of curcumin against fructose-induced hyperuricaemia and renal endothelial dysfunction involves NO-mediated JAK-STAT signalling in rats. Food Chem. 134:2184–2193. 2012. View Article : Google Scholar : PubMed/NCBI | |
Tew WY, Tan CS, Asmawi MZ and Yam MF: Underlying mechanism of vasorelaxant effect exerted by 3,5,7,2′,4′-pentahydroxyflavone in rats aortic ring. Eur J Pharmacol. 880:1731232020. View Article : Google Scholar : PubMed/NCBI | |
Yang J, Wang R, Cheng X, Qu H, Qi J, Li D, Xing Y, Bai Y and Zheng X: The vascular dilatation induced by Hydroxysafflor yellow A (HSYA) on rat mesenteric artery through TRPV4-dependent calcium influx in endothelial cells. J Ethnopharmacol. 256:1127902020. View Article : Google Scholar : PubMed/NCBI | |
Xu J, Zhang C, Shi X, Li J, Liu M, Jiang W and Fang Z: Efficacy and safety of sodium tanshinone IIA sulfonate injection on hypertensive nephropathy: A systematic review and meta-analysis. Front Pharmacol. 10:15422019. View Article : Google Scholar : PubMed/NCBI | |
Li P, Peng Y, Ma Q, Li Z and Zhang X: Study on the formation of antihypertensive twin drugs by caffeic acid and ferulic acid with telmisartan. Drug Des Devel Ther. 14:977–992. 2020. View Article : Google Scholar : PubMed/NCBI | |
He F, Chu JF, Chen HW, Lin W, Lin S, Chen YQ, Peng J and Chen KJ: Qingxuan Jiangya decoction () prevents blood pressure elevation and ameliorates vascular structural remodeling via modulating TGF-β 1/Smad pathway in spontaneously hypertensive rats. Chin J Integr Med. 26:180–187. 2020. View Article : Google Scholar : PubMed/NCBI | |
Ye F, He J, Wu X, Xie J, Chen H, Tang X, Lai Z, Huang R and Huang J: The regulatory mechanisms of Yulangsan MHBFC reversing cardiac remodeling in rats based on eNOS-NO signaling pathway. Biomed Pharmacother. 117:1091412019. View Article : Google Scholar : PubMed/NCBI | |
Li W, Jiang YH, Wang Y, Zhao M, Hou GJ, Hu HZ and Zhou L: Protective effects of combination of radix astragali and radix salviae miltiorrhizae on kidney of spontaneously hypertensive rats and renal intrinsic cells. Chin J Integr Med. 26:46–53. 2020. View Article : Google Scholar : PubMed/NCBI | |
Ma C, Zhai C, Xu T, Lu F, Zhang S, Li C, Wang Q, Cheng F and Wang X: A systems pharmacology-based study of the molecular mechanisms of San Cao decoction for treating hypertension. Evid Based Complement Alternat Med. 2019:31714202019. View Article : Google Scholar : PubMed/NCBI | |
Tanaka M and Itoh H: Hypertension as a metabolic disorder and the novel role of the gut. Curr Hypertens Rep. 21:632019. View Article : Google Scholar : PubMed/NCBI | |
Hall JE, do Carmo JM, da Silva AA, Wang Z and Hall ME: Obesity, kidney dysfunction and hypertension: Mechanistic links. Nat Rev Nephrol. 15:367–385. 2019. View Article : Google Scholar : PubMed/NCBI | |
Bell DS: Treatment of diabetic hypertension. Diabetes Obes Metab. 11:433–444. 2009. View Article : Google Scholar : PubMed/NCBI | |
Busija DW, Miller AW, Katakam P and Erdös B: Insulin resistance and associated dysfunction of resistance vessels and arterial hypertension. Minerva Med. 96:223–232. 2005.PubMed/NCBI | |
Eringa EC, Bakker W and van Hinsbergh VW: Paracrine regulation of vascular tone, inflammation and insulin sensitivity by perivascular adipose tissue. Vascul Pharmacol. 56:204–209. 2012. View Article : Google Scholar : PubMed/NCBI | |
Gamboa-Gómez C, Pérez-Ramírez IF, González-Gallardo A, Gallegos-Corona MA, Ibarra-Alvarado C and Reynoso-Camacho R: Effect of Citrus paradisi and Ocimum sanctum infusions on blood pressure regulation and its association with renal alterations in obese rats. J Food Biochem. 40:345–357. 2016. View Article : Google Scholar | |
Ren Y, Wang D, Lu F, Zou X, Xu L, Wang K, Huang W, Su H, Zhang C, Gao Y and Dong H: Coptidis rhizoma inhibits NLRP3 inflammasome activation and alleviates renal damage in early obesity-related glomerulopathy. Phytomedicine. 49:52–65. 2018. View Article : Google Scholar : PubMed/NCBI | |
Liu BL, Chen YP, Cheng H, Wang YY, Rui HL, Yang M, Dong HR, Han DN and Dong J: The protective effects of curcumin on obesity-related glomerulopathy are associated with inhibition of Wnt/β-catenin signaling activation in podocytes. Evid Based Complement Alternat Med. 2015:8274722015. View Article : Google Scholar : PubMed/NCBI | |
Ma L, Huang L, Pei H, Liu Z, Xie C, Lei L, Chen X, Ye H, Peng A and Chen L: Pharmacological effects of the water fraction of key components in the traditional Chinese prescription Mai Tong Fang on 3T3-L1 adipocytes and ob/ob diabetic mice. Molecules. 19:14687–14698. 2014. View Article : Google Scholar : PubMed/NCBI | |
Basile J and Toth P: Angiotensin receptor blockers: Role in hypertension management, cardiovascular risk reduction, and nephropathy. South Med J. 102 (10 Suppl):S1–S12. 2009. View Article : Google Scholar : PubMed/NCBI | |
Pirkle JL and Freedman BI: Hypertension and chronic kidney disease: Controversies in pathogenesis and treatment. Minerva Urol Nefrol. 65:37–50. 2013.PubMed/NCBI | |
Yang C, Wang H, Zhao X, Matsushita K, Coresh J, Zhang L and Zhao MH: CKD in China: Evolving spectrum and public health implications. Am J Kidney Dis. 76:258–264. 2020. View Article : Google Scholar : PubMed/NCBI | |
Leong XF, Ng CY and Jaarin K: Animal models in cardiovascular research: Hypertension and atherosclerosis. Biomed Res Int. 2015:5287572015. View Article : Google Scholar : PubMed/NCBI | |
Meili-Butz S, Bühler K, John D, Buser P, Vale WW, Peterson KL, Brink M and Dieterle T: Acute effects of urocortin 2 on cardiac function and propensity for arrhythmias in an animal model of hypertension-induced left ventricular hypertrophy and heart failure. Eur J Heart Fail. 12:797–804. 2010. View Article : Google Scholar : PubMed/NCBI | |
Liu ML, Song HX, Tian XX, Liu YX, Liu D, Hou ZW, Li JY, Yan CH and Han YL: Recombinant cellular repressor of E1A-stimulated genes protects against renal fibrosis in Dahl salt-sensitive rats. Am J Nephrol. 51:401–410. 2020. View Article : Google Scholar : PubMed/NCBI | |
Lu Q, Ma Z, Ding Y, Bedarida T, Chen L, Xie Z, Song P and Zou MH: Circulating miR-103a-3p contributes to angiotensin II-induced renal inflammation and fibrosis via a SNRK/NF-κB/p65 regulatory axis. Nat Commun. 10:21452019. View Article : Google Scholar : PubMed/NCBI | |
Han WQ, Xu L, Tang XF, Chen WD, Wu YJ and Gao PJ: Membrane rafts-redox signalling pathway contributes to renal fibrosis via modulation of the renal tubular epithelial-mesenchymal transition. J Physiol. 596:3603–3616. 2018. View Article : Google Scholar : PubMed/NCBI | |
Su Y, Deng X, Ma R, Dong Z, Wang F and Shi J: The Exposure of phosphatidylserine influences procoagulant activity in retinal vein occlusion by microparticles, blood cells, and endothelium. Oxid Med Cell Longev. 2018:36584762018. View Article : Google Scholar : PubMed/NCBI |